The key protease responsible for the processing of the proglucagon peptide into GLP-1 is Psck1/3, which has shown to be upregulated in -cells during hyperglycaemic, hyperlipidemic, or inflammatory conditions to promote glucose-induced glucagon suppression, a compensatory response to a metabolic insult as in type 2 diabetes (205)
The FDA reportedly contacted the manufacturer suggesting that the drug had not been marketed in a truthful and non-misleading way
Long-term safety data are still limited, especially regarding potential impacts on mental health and metabolic development during adolescence
Cancer cells dependence on glutamine could also serve as a basis for tailoring therapies to specific people
We work diligently to obtain and maintain third-party analytical reports (HPLC/LC-MS) and Certificates of Analysis for each batch, as part of our ongoing quality process
Ongoing research, including the semaglutide EVOKE trials in Alzheimer's disease, may provide more definitive evidence